August 17, 2026 06:41 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar | Bengal man arrested in Bengaluru over terror links, Afghanistan travel plan | Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe
Photo courtesy: x.com/PiyushGoyal

Piyush Goyal discusses investment avenues with existing and potential US investors

| @indiablooms | Oct 02, 2024, at 06:27 am

New York: Commerce and Industry Minister Piyush Goyal chaired a roundtable discussion with young CEOs and entrepreneurs of Indian origin in New York organised by the Consulate General of India to discuss the business landscape of India and provide suggestions for reforms.

Highlighting various reforms in India over the last decade, Minister Goyal invited American companies to leverage “India’s unmatched scale and take advantage of the ‘Make in India’ initiative, particularly in high-tech manufacturing and quality production.”

Goyal also held one-on-one meetings with several CEOs discussing new areas of collaboration, particularly in advanced manufacturing, pharmaceuticals, robotics, artificial intelligence, and sustainable technologies.

He met Amneal Pharmaceuticals’ Co-CEO Chintu Patel and President & Co-CEO Chirag Patel.

They explored ways to enhance India’s pharmaceutical ecosystem for high-end R&D, including biologics, and improved manufacturing capabilities to establish a robust global supply chain, the press release said.

The minister also held a meeting with Henry R. Kravis, Co-Founder & Co-Executive Chairman of Kohlberg Kravis Roberts & Co. (KKR).

Minister Goyal highlighted potential investment opportunities in India's electronics manufacturing, data infrastructure, and logistics sectors.

He underscored the consistent economic growth in India over the past decade and the vast consumer market, which present numerous opportunities for strategic investments.

In his meeting with Blackstone CEO Stephen Schwarzman, Minister Goyal noted that the company has already invested about USD 50 billion in India and is one of the largest commercial and real estate investors in India.

The Union minister highlighted the potential for infrastructure development in India, wherein the emphasis of the government is to develop quality infrastructure in the country for improving living standards, making it easier to do business and reducing logistics costs.

The president of Warburg Pincus, Timothy F. Geithner also called on the minister for a one-on-one discussion that covered various areas where there is scope for further improving the ease of doing business.

He will continue with his meetings with the business community in New York on day-2 of his visit before he proceeds for the bilateral meetings in Washington DC.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.